Sweden · Delayed Price · Currency is SEK Physitrack Earnings Call Transcripts
Fiscal Year 2026
-
Achieved profitability in Q1 2026 with strong recurring revenue and robust margins. Strategic focus on North America and RTM launch positions the business for accelerated growth, with margin recovery and share buyback program expected in H2 2026.
Fiscal Year 2025
-
2025 saw a strategic shift to profitability, with adjusted EBITDA margin rising to 35% and free cash flow turning positive. Lifecare drove stable growth, while Wellness was restructured for higher margins. North America is a key focus for future expansion.
-
Q3 2025 saw strong profitability, with free cash flow up 200% year-on-year and SaaS revenue at 88% of total. Lifecare drove growth with high margins, while Wellness was streamlined for future scalability. ARR is expected to stabilize and return to growth in 2026.
-
Q2 saw a historic swing to positive cash flow and margin expansion, driven by a shift to 87% recurring revenue and strong Lifecare performance. Wellness SaaS ARR surged 109% year-over-year, and the group is targeting doubled revenue and 40-45% EBITDA margins in the medium term.
-
Q1 2025 saw 3% group revenue growth, led by Lifecare's 6% rise and strong SaaS metrics, while Wellness revenue declined due to strategic exits. Adjusted EBITDA margin reached 31%, and the business remains cash flow positive, with a focus on scalable SaaS growth.
Fiscal Year 2024
-
Q4 2024 delivered 14% revenue growth and a 24% adjusted EBITDA margin, with both Lifecare and Wellness divisions contributing. Major restructuring and product innovation set the stage for 2025, with stable CapEx and a focus on margin expansion and cash flow generation.
-
Q3 2024 saw strong subscription revenue growth and Lifecare outperformance, offset by wellness division delays and cash flow challenges. Management expects a return to cash flow neutrality by year-end, with new product launches and operational synergies set to drive future growth.
-
Revenue grew 5% year-over-year in Q2, with subscription revenue up 21% and now 82% of total business. Lifecare led growth with strong margins, while Wellness faced seasonal headwinds but expects improvement from new product launches.